9:00 a.m. – 9:30 a.m.

Registration & Networking

9:30 a.m. – 9:45 a.m.

Welcome & Opening Remarks

• Debbie Hart, President & CEO, BioNJ
• Jianmin Qu, Ph.D., Provost, Stevens Institute of Technology
• David Fritz, Regional Managing Director, Morgan Stanley
• Lisa LeCointe-Cephas, J.D., Partner, DLA Piper 

9:45 a.m. – 10:15 a.m.

Keynote / Industry Overview

To kick off the program, an industry expert from Morgan Stanley will discuss trends in AI and digital health and how they are transforming the biopharma industry.

Keynote by Mark Parsonson, MBA, Executive Director, Healthcare Investment Banking, Morgan Stanley

10:20 a.m. – 11:00 a.m.

Lightning Pitches

90-second introductions by companies using AI or digital health innovations to change the healthcare industry

11:00 a.m. – 11:30 a.m.

Networking Break & Help Desks

Network with attendees and speakers; plus, schedule a time to meet one-on-one with representatives from financial, legal, payer, provider and investor organizations.

11:30 a.m. – 12:00 p.m.

Panel: Getting Started with AI

A panel of experts will provide a practical guide for those looking to integrate AI into their organizations. Experts will discuss foundational strategies, key considerations such as data management and security concerns, and real-world AI applications being utilized today to drive innovation, improve research outcomes and enhance Patient care.

• Barclay Blair, Sr. Managing Director, AI Innovation Team, DLA Piper
• Neil Patel, Head, Analytics Experience, Artificial Intelligence, Data & Analytics Group, Pfizer
• Tyrone Richardson, MBA, Chief Commercial Officer, Rycht
• Joe Szustakowski, Vice President, Head, Clinical Development Data Science & AI, Genmab
• Moderated by: Allen Waxman, Of Counsel, J.D., DLA Piper

12:05 p.m. – 1:05 p.m.

Lunch & Networking

1:15 p.m. – 2:00 p.m.

Panel: Using AI to Reduce the Time from Idea to Approval

In this session, industry leaders will explore how AI is accelerating the drug and device development process. From streamlining research and clinical trials to navigating regulatory pathways, this panel will highlight innovative AI applications that shorten timelines and enhance efficiency, ultimately speeding up the journey from concept to market approval.

• Hannah Barnett, MBA, Director, Digital Strategic Partnerships, Sanofi
• Daniela Brunner, Ph.D., CIO & CTO, PsychoGenics
• Tyler Bryk, Head, Artificial Intelligence, PTC Therapeutics
• Kiran Dattani, MBA, MPH, Customer Success, Transformation, Strategy & Architecture, Google Cloud

2:05 p.m. – 2:45 p.m.

Panel: How AI is Accelerating the Path from Approval to Better Patient Outcomes 

Industry and academic experts will discuss how AI-powered tools are optimizing treatment delivery, enhancing Patient monitoring and driving personalized care to improve outcomes. Learn how these organizations are using AI and digital solutions to bridge the gap and accelerate the process from regulatory approval to real-world clinical success.

• Brian Dobosh, MBA, Vice President, Digital Experience, Population Health, Research, & Genomics, RWJBarnabas Health 
• Sang Won Bae, Ph.D., Assistant Professor, Department of Systems and Enterprises, Stevens Institute of Technology
• Jot Chahal, MBA, Vice President, Global Digital Health, Johnson & Johnson Innovative Medicine
• Raj Kanduri, Senior Director, Enterprise Architecture, Horizon Blue Cross Blue Shield of New Jersey
• Moderated by: David Frigeri, Managing Director, AI, Slalom

2:50 p.m. – 3:05 p.m.

Awards Presentation

Lightning Pitch Awards to be presented by BioNJ and Phil Crowley of Crowley Law

3:10 p.m. – 3:25 p.m.

Conclusions and Closing Remarks

• Debbie Hart, President & CEO, BioNJ
• Michael Malz, CFP, MBA, Executive Director & Betsy McNeilly, CFP, MBA, Executive Director, Morgan Stanley
• Lisa LeCointe-Cephas, J.D., Partner, DLA Piper
• Nariman Farvardin, Ph.D., President, Stevens Institute of Technology 

3:30 p.m. – 4:30 p.m.

Networking Reception